Armonk, N.Y. - 07 Apr 2017: IBM (NYSE: IBM) today announced that its scientists have been granted a patent on machine learning models to predict therapeutic indications and side effects from various drug information sources. IBM Research has implemented a cognitive association engine to identify significant linkages between predicted therapeutic indications and side effects, and a visual analytics system to support the interactive exploration of these associations.
IBM News room - 2017-04-07 IBM Patents Machine Learning Models for Drug Discovery - United States
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.